FDA Extends Review for Salix Diarrhea Drug

The Food and Drug Administration has extended by three months the review date for an experimental pill to treat HIV treatment-related diarrhea, according to Salix Pharmaceuticals, the drug’s maker.

FDA had been scheduled to review the drug, crofelemer, on June 5. Salix said in a statement that FDA said it needs more time for a full review, although it did not ask for any additional studies.

The Friends of AIDS Foundation is dedicated to enhancing the quality of life for HIV positive individuals and empowering people to make healthy choices to prevent the spread of the HIV virus. To learn more about The Friends of AIDS Foundation, please visit: http://www.friendsofaids.org.

TOGETHER WE REMAIN STRONG!